Filed 2.7y ago· Sep 5, 2023
11 days to disclose
Thomas R Carper
DSenateDelaware
↓sold
Intellia Therapeutics
NTLA
$1K-$15K
+126.6% vs S&P 500
Trade dateAug 25, 2023
Intellia Therapeutics, Inc. -
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–7 of 7
Filed 2.9y ago· Jun 30, 2023
39 days to discloseThomas R Carper
DSenateDelaware
↑bought
Intellia Therapeutics
NTLA
$1K-$15K
−139.8% vs S&P 500
Trade dateMay 22, 2023
Intellia Therapeutics, Inc. -
Filed 4.3y ago· Mar 3, 2022
3 days to disclose
Donald S. Beyer Jr.
DHouseVirginia-08
↓sold
Intellia Therapeutics
NTLA
$15K-$50K
+149.7% vs S&P 500
Trade dateFeb 28, 2022
⚑ Pharmaceutical
Filed 4.6y ago· Oct 30, 2021
1 day to discloseDonald S. Beyer Jr.
DHouseVirginia-08
↓sold
Intellia Therapeutics
NTLA
$1K-$15K
+145.2% vs S&P 500
Trade dateOct 29, 2021
⚑ Pharmaceutical
Filed 4.7y ago· Oct 1, 2021
11 days to discloseDonald S. Beyer Jr.
DHouseVirginia-08
↓sold
Intellia Therapeutics
NTLA
$1K-$15K
+155.3% vs S&P 500
Trade dateSep 20, 2021
⚑ Pharmaceutical
Filed 4.8y ago· Aug 7, 2021
17 days to discloseDonald S. Beyer Jr.
DHouseVirginia-08
↓sold
Intellia Therapeutics
NTLA
$1K-$15K
+155.4% vs S&P 500
Trade dateJul 21, 2021
⚑ Pharmaceutical
Filed 5.0y ago· May 17, 2021
178 days to disclose · 133 past 45-day windowThomas R Carper
DSenateDelaware
↑bought
Intellia Therapeutics
NTLA
$1K-$15K
Trade dateNov 20, 2020
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Sep 5, 2023 2.7y ago | Thomas R Carper DSenateDelaware | ↓sold | Intellia Therapeutics NTLA Intellia Therapeutics, Inc. - | Aug 25, 2023 11 days to disclose | Smart sell·+$5.1K+64.4% +126.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 30, 2023 2.9y ago | Thomas R Carper DSenateDelaware | ↑bought | Intellia Therapeutics NTLA Intellia Therapeutics, Inc. - | May 22, 2023 39 days to disclose | Bad buy·−$5.5K-69.3% −139.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 3, 2022 4.3y ago | Donald S. Beyer Jr. DHouseVirginia-08 | ↓sold | Intellia Therapeutics NTLA ⚑ Pharmaceutical · Ways and Means | Feb 28, 2022 3 days to disclose | Smart sell·+$28K+86.2% +149.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 30, 2021 4.6y ago | Donald S. Beyer Jr. DHouseVirginia-08 | ↓sold | Intellia Therapeutics NTLA ⚑ Pharmaceutical · Ways and Means | Oct 29, 2021 1 day to disclose | Smart sell·+$7.2K+89.8% +145.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 1, 2021 4.7y ago | Donald S. Beyer Jr. DHouseVirginia-08 | ↓sold | Intellia Therapeutics NTLA ⚑ Pharmaceutical · Ways and Means | Sep 20, 2021 11 days to disclose | Smart sell·+$7.3K+90.8% +155.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 7, 2021 4.8y ago | Donald S. Beyer Jr. DHouseVirginia-08 | ↓sold | Intellia Therapeutics NTLA ⚑ Pharmaceutical · Ways and Means | Jul 21, 2021 17 days to disclose | Smart sell·+$7.3K+91.1% +155.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 17, 2021 5.0y ago | Thomas R Carper DSenateDelaware | ↑bought | Intellia Therapeutics NTLA | Nov 20, 2020 178 days to disclose · 133 past 45-day window | price pending | $1K-$15K midpoint $8K |